Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.

Velo-cardio-facial-syndrome (VCFS) is a common congenital disorder associated with typical facial appearance, cleft palate, cardiac defects, and learning disabilities. The majority of patients have an interstitial deletion on chromosome 22q11. In addition to physical abnormalities, a variety of psychiatric illnesses have been reported in patients with VCFS, including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder. The psychiatric manifestations of VCFS could be due to haploin-sufficiency of a gene(s) within 22q11. One candidate that has been mapped to this region is catechol-O-methyltransferase (COMT). We recently identified a polymorphism in the COMT gene that leads to a valine-->methionine substitution at amino acid 158 of the membrane-bound form of the enzyme. Homozygosity for COMT158met leads to a 3-4-fold reduction in enzymatic activity, compared with homozygotes for COMT158val. We now report that in a population of patients with VCFS, there is an apparent association between the low-activity allele, COMT158met, and the development of bipolar spectrum disorder, and in particular, a rapid-cycling form.

[1]  J. Axelrod,et al.  Enzymatic O-methylation of epinephrine and other catechols. , 1958, The Journal of biological chemistry.

[2]  R. Fieve,et al.  Erythrocyte catechol-o-methyltransferase activity in primary affective disorder. , 1977, Biological psychiatry.

[3]  B. Herjanic,et al.  Differentiating psychiatrically disturbed children on the basis of a structured interview , 1977, Journal of abnormal child psychology.

[4]  R. Weinshilboum,et al.  Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. , 1977, American journal of human genetics.

[5]  R. Shprintzen,et al.  A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. , 1978, The Cleft palate journal.

[6]  R. Weinshilboum,et al.  Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. , 1979, Science.

[7]  J. Hoo,et al.  Catechol-O-methyltransferase of erythrocytes in patients with endogenous psychoses , 1981, Psychiatry Research.

[8]  R. Weinshilboum,et al.  Genetics of red cell COMT activity: analysis of thermal stability and family data. , 1981, American journal of medical genetics.

[9]  M. Załuska,et al.  Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness , 1983, Acta psychiatrica Scandinavica.

[10]  M. Załuska,et al.  Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness , 1983, Acta psychiatrica Scandinavica.

[11]  R. Tissot,et al.  The decrease of erythrocyte catechol‐O‐methyltransferase activity in depressed patients and its diagnostic significance , 1987, Acta psychiatrica Scandinavica.

[12]  R. Weinshilboum,et al.  Human liver catechol‐O‐methyltransferase pharmacogenetics , 1990, Clinical pharmacology and therapeutics.

[13]  Z Dembic,et al.  Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Jalanko,et al.  Cloning and Characterization of Human Placental Catechol--Methyltransferase cDNA , 1991 .

[15]  R. Shprintzen,et al.  Late-onset psychosis in the velo-cardio-facial syndrome. , 1992, American journal of medical genetics.

[16]  D. Diehl,et al.  The role of dopamine in mood disorders. , 1992, Comprehensive psychiatry.

[17]  R. Shprintzen,et al.  The velo-cardio-facial syndrome is associated with chromosome 22 deletions which encompass the DiGeorge syndrome locus , 1992 .

[18]  B. Emanuel,et al.  Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2. , 1992, Genomics.

[19]  R. Shprintzen,et al.  Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus , 1992, The Lancet.

[20]  R. Shprintzen,et al.  Velo-cardio-facial syndrome: a review of 120 patients. , 1993, American journal of medical genetics.

[21]  I. Dunham,et al.  Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. , 1993, Human molecular genetics.

[22]  S. Aksoy,et al.  Catechol O-methyltransferase pharmacogenetics: photoaffinity labelling and western blot analysis of human liver samples. , 1993, Pharmacogenetics.

[23]  R. Weksberg,et al.  Velo-cardio-facial syndrome and psychotic disorders: implications for psychiatric genetics. , 1994, American journal of medical genetics.

[24]  T. Kiviluoto,et al.  Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. , 1994, European journal of biochemistry.

[25]  D. Housman,et al.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. , 1994, The Journal of nervous and mental disease.

[26]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[27]  L. Cottler,et al.  Computerized interviews as a method of assessing psychopathology in children. , 1995, Comprehensive psychiatry.

[28]  I. Dunham,et al.  Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. , 1995, American journal of human genetics.

[29]  N J Cox,et al.  Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.

[30]  R. Kucherlapati,et al.  Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. , 1995, American journal of medical genetics.

[31]  L. Altshuler Premenstrual Dysphonias: Myths and Realities , 1995 .

[32]  L. Altshuler,et al.  Antidepressant-induced mania and cycle acceleration: a controversy revisited. , 1995, The American journal of psychiatry.

[33]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[34]  W. Reich,et al.  Development of a structured psychiatric interview for children: Agreement between child and parent on individual symptoms , 1982, Journal of abnormal child psychology.